Javier Ruiz‐Guiñazú

Also affiliated with Johnson & Johnson (Israel), Johnson & Johnson (Netherlands)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S”.

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

New England Journal of Medicine(2022)10.1056/nejmoa2117608

N/A

4.6DataRank · unranked

251 citations

Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn +24 more

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00506-0

N/A

2.0DataRank · unranked

89 citations

An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, D. Lowson +95 more

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trial

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103016

N/A

0.249DataRank · unranked

4 citations

Gloria Aguilar, Nathalie Vaissière, Carla Truyers, Pedro Ylisastigui, Erik Buntinx +15 more

Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis

Expert Review of Anti-infective Therapy(2025)10.1080/14787210.2025.2569833

N/A

0.165DataRank · unranked

2 citations

Nada Abaza, Mirna Fasseeh, Rawda Elshahawy, Yosra S. Mahmoud, Hassan Hendawy +15 more

Durability of antibody responses elicited by a single dose of Ad26.COV2.S and substantial increase following late boosting

medRxiv(2021)10.1101/2021.08.25.21262569

N/A

0DataRank · unranked

23 citations

Mathieu Le Gars, Vicky Cárdenas, Georgi Shukarev, Nathalie Vaissière, Dirk Heerwegh +10 more

Quantifying Antibody Persistence After a Single Dose of COVID‐19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2796

N/A

0DataRank · unranked

8 citations

Muriel Boulton, Martine Neyens, Mathieu Le Gars, Belén Valenzuela, Georgi Shukarev +6 more

Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16–17 Years of Age

Journal of the Pediatric Infectious Diseases Society(2024)10.1093/jpids/piae098

N/A

0DataRank · unranked

0 citations

Mathieu Le Gars, Vicky Cárdenas, Nathalie Vaissière, Jerald Sadoff, Carla Truyers +7 more